Abraaj pulls out from Tunisian pharma company

02 Nov 2013

(MENAFN) Dubai’s Abraaj Group said that it is pulling out from Tunisian pharmaceutical company Opalia Pharma, Arabian Business reported.

The firm said that it has sold its shares to an international pharmaceutical company called Recordati.

The Abraaj Group first invested in Opalia in 2009 in a deal that marked the Group’s first realisation in the Tunisian market.

Since Then, Abraaj’s involvement with the pharmaceutical company aided in doubling sales.

More News

This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more

This site is registered on as a development site.